期刊文献+

Cys C对脓毒症患者生存状况的预测价值

Value of Cys C to predict survival in patients with sepsis
下载PDF
导出
摘要 目的探讨脓毒症患者入ICU时的血Cys C水平对患者病情及预后的评估意义。方法回顾性分析2016年7月~2017年7月我院ICU收治的107例脓毒症诊断成立48h以内的患者为研究对象,按照患者住院期间的预后情况分为存活组(n=50)及死亡组(n=57)。比较两组患者入ICU 24h内的血PCT、BUN、SCr、Cys C及APACHEⅡ评分,并绘制ROC曲线分析上述各指标预测脓毒症患者病情及预后的价值。结果两组患者性别构成及年龄组间比较均无统计学差异(P>0.05);两组患者入住ICU 24h内的APACHEⅡ、PCT、BUN、SCr、Cys C等指标,死亡组均高于存活组,差异有统计学意义(P<0.05);脓毒症患者入ICU 24h内的APACHEⅡ、PCT、BUN、SCr、Cys C水平对预测患者住院期间死亡情况的ROC曲线分析显示:APACHEⅡ、PCT、BUN、SCr、Cys C曲线下面积分别为0.748、0.694、0.698、0.722、0.772,以APACHEⅡ≥23.5、PCT≥37.46 ng/ml、BUN≥11.65 mmol/L、SCr≥124.55μmol/L、Cys C≥1.91mg/L为截断点,其预测脓毒症患者住院期间死亡的灵敏度和特异度分别为61.4%、54.4%、66.7%、68.4%、57.9%和78%、80%、68%、76%、88%。结论脓毒症患者进入ICU时的血Cys C水平可用于指导评估患者的病情及预后。 Objective To investigate the significance of serum Cys C level in patients with sepsis on the condition and prognosis of patients in ICU. Methods A retrospective analysis of 107 patients with sepsis within 48 hours from Jul 2016 to Jul 2017 in ICU of our hospital was carried out. According to the prognosis of the patients in hospital,the patients were divided into survival group(n=50) and death group(n=57). The score of blood APACHE Ⅱ and Cys C of patients in ICU within 24 hours were compared. The ROC curve was plotted to analyze the value of the above indexes in predicting the condition and prognosis of sepsis patients. Results There was no significant difference in gender and age between two groups(P〈0.05). The value of APACHE Ⅱ,PCT,BUN,SCr,Cys C in death group were significant higher than survival group(P〈0.05). The area under the ROC curve of APACHE Ⅱ,PCT,BUN,SCr,Cys C were 0.748,0.694,0.698,0.722,0.772 respectively,using APACHE Ⅱ≥23.5,PCT≥37.46 ng/ml BUN≥11.65 mmol/L,SCr≥124.55μmol/L,Cys C≥1.91 mg/L as the cut-off point,the sensitivity of each index to predict the death rate of sepsis patients were 61.4%,54.4%,66.7%,68.4%,57.9% respectively,and their specificity were 78%,80%,68%,76%,88%. Conclusion The level of blood Cys C in patients with sepsis when entering ICU can be used as an ideal indicator for guiding the assessment of the patients' condition and prognosis.
出处 《中国现代医药杂志》 2018年第1期11-13,共3页 Modern Medicine Journal of China
基金 遵义市联合基金(遵市科合社字[2016]14号)
关键词 脓毒症 CYS C 预后 Sepsis Cys C Prognosis
  • 相关文献

参考文献2

二级参考文献30

  • 1OBrien JM Jr,Lu B. Insurance type and sepsis -associated hospitaliza- tions and sepsis -associated mortality among US adults :a retmspective cohort study[ J]. Cfit Care,2011,15(3) :130-132.
  • 2Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign :in- ternational guidelines for management of severe sepsis and septic shock [J]. Crit Care Med,2008,36(1) :296 -327,.
  • 3Okorie ON, Dellinger P. Lactate:biomarker and potential therapeu- tic target[J]. Crit Care Clin,2011,27(2) :299.
  • 4Nguyen HB, Loomba M. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunc- tion and mortality in severe sepsis and septic shock [ J ] Inflamma- tion,2010,7 ( 1 ) :6 - 8.
  • 5Schneider J, Khemani R, Grushkin C, et al. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit[J]. Crit Care Med, 2010, 38(3): 933-939.
  • 6Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury[J]. Kidney Int, 2007, 71(10): 1028-1035.
  • 7Devarajan P. Neutrophil gelatinase-associated lipocalin. a troponin-like biomarker for human acute kidney injury[J]. Nephrology (Carlton), 2010, 15(4): 419-428.
  • 8Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2008, 17(2): 127-132.
  • 9Devarajan P. Update on mechanisms of ischemic acute kidney injury[J]. J Am Soc Nephrol, 2006, 17(6): 1503-1520.
  • 10Murray PT, Devarajan P, Levey AS, et al. A framework and key research questions in AKI diagnosis and staging in different environments[J]. Clin J Am Soc Nephrol, 2008, 3(3): 864-868.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部